NCT02596802View on ClinicalTrials.gov

Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Congenital Diaphragm Hernia

NAActive, not recruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 1, 2015

Primary Completion Date

December 20, 2024

Study Completion Date

January 20, 2026

Conditions
Congenital Diaphragmatic Hernia
Interventions
DEVICE

FETO therapy

Fetoscopic surgery at 27 to 31 weeks and 6 days gestation.

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
lead

Anthony Johnson

OTHER

NCT02596802 - Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Congenital Diaphragm Hernia | Biotech Hunter | Biotech Hunter